Clinical and pathogenetic features of thyropathies diagnosed during the post-COVID-19 period

Introduction. The past COVID-19 pandemic has influenced the course of many diseases including endocrine pathology. However, little is known about the clinical and pathogenetic features of thyroid pathology of the post-COVID-19 period.

Aim. Evaluate the clinical and pathogenetic features of thyropathies diagnosed during the post-COVID-19 period.

Materials and methods. A cross-sectional study included 250 patients with newly diagnosed thyroid diseases. 73 participants denied a history of COVID-19 and 177 suffered from it within the previous 9 months. Thyroid status and thyroid ultrasound examination were assessed. IgG SARS-Cov-2 levels were tested in 40 patients with a history of COVID-19. Fine needle aspiration biopsy was performed in 61 patients including 41 with a history of COVID-19. In the main group, all the samples were additionally investigated by immunocytochemical analysis with SARS-CoV-2 protein antibodies.

Results. Among the patients with COVID-19 history higher levels of fT4 (13.6 [12.4; 15.5] vs 12.8 [11.0; 15.3] pmol/l, p = 0.046) and a lower proportion of patients with euthyroidism (122 (68.9%) vs 59 (80.8%), p = 0.037) were detected. In the main group there were more cytological samples with macrophages accumulations (16 (39.0%) vs 2 (10.0%), p = 0.017), however, immu-nocytochemical study did not reveal any SARS-Cov-2-positive samples. During the post-COVID-19 period, approximately 60% of patients with subclinical thyroid dysfunctions experienced spontaneous normalization. There were correlations between IgG SARS-Cov-2 levels and parameters characterizing the structural and functional state of the thyroid gland.

Conclusion. The most typical clinical feature of post-COVID-19 thyropathies was a smaller proportion of individuals with euthyroidism. Mild thyroid dysfunctions identified during the post-COVID-19 period tended to develop spontaneous normalization in 60% of cases. The immunocytochemical tests indicate the absence of SARS-Cov-2 persistence in the thyroid tissue. COVID-19- associated immunopathological reactions are involved in the pathogenesis of post-COVID-19 thyropathies.

1. Chen W, Lei J, Li Z. Thyroid function changes and COVID-19 severity: egg or chicken? Endocrine. 2022;78(3):436-440. https://doi.org/10.1007/s12020-022-03129-1.

2. Poma AM, Basolo A, Bonuccelli D, Proietti A, Macerola E, Ugolini C et al. Activation of type I and type II interferon signaling in SARS-CoV-2-Positive thyroid tissue of patients dying from COVID-19. Thyroid. 2021;31(12):1766-1775. https//doi.org/101089/thy.2021.0345.

3. Rossetti CL, Cazarin J, Hecht F, Beltrao FEL, Ferreira ACF, Fortunato RS et al. COVID-19 and thyroid function: What do we know so far? Front Endocrinol (Lausanne). 2022;13:1041676. https://doi.org/10.3389/fendo.2022.1041676.

4. Naguib R. Potential relationships between COVID-19 and the thyroid gland: an update. J Int Med Res. 2022;50(2):3000605221082898. https://doi.org/10.1177/03000605221082898.

5. Kolpakova EA, Elfimova AR, Nikankina LV, Troshina EA. The role of systemic immune activation in the development of thyroid dysfunction in COVID-19. Terapevticheskii Arkhiv. 2022;94(10):1136-1142. (In Russ.) https://doi.org/10.26442/00403660.2022.10.201879.

6. Kolpakova EA, Elfimova AR, Nikankina LV, Dyakov IN, Bushkova KK, Troshina EA. COVID-19 and the possible development of autoimmune thyroid diseases. Clinical and Experimental Thyroidology. 2022;18(3):4-12. (In Russ.) https://doi.org/10.14341/ket12740.

7. Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. https://doi.org/10.1186/s40249-020-00662-x.

8. Ruggeri RM, Campennì A, Deandreis D, Siracusa M, Tozzoli R, Petranović Ovčariček P, Giovanella L. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol. 2021;17(7):737-759. https://doi.org/10.1080/1744666X.2021.1932467.

9. Churilov LP, Normatov MG, Utekhin VJ. Molecular Mimicry between SARS- CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity? Pathophysiology. 2022;29(3):486-494. https://doi.org/10.3390/pathophysiology29030039.

10. Caron P. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management. Endocrine. 2022;78(3):406-417. https://doi.org/10.1007/s12020-022-03118-4.

11. Vojdani A, Vojdani E, Kharrazian D. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Front Immunol. 2021;11:617089. https://doi.org/10.3389/fimmu.2020.617089.

12. Boaventura P, Macedo S, Ribeiro F, Jaconiano S, Soares P. Post-COVID-19 Condition: Where Are We Now? Life (Basel). 2022;12(4):517. https://doi.org/10.3390/life12040517.

13. Mehta A, Andrew Awuah W, Yarlagadda R, Kalmanovich J, Huang H, Kundu M, Nansubuga EP, Lopes L, Ghosh B, Hasan MM. Investigating thyroid dysfunction in the context of COVID-19 infection. Ann Med Surg (Lond). 2022;31:104806. https://doi.org/10.1016/j.amsu.2022.104806.

14. Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381-387. https://doi.org/10.1530/EJE-20-0335.

15. Tutal E, Ozaras R, Leblebicioglu H. Systematic review of COVID-19 and autoimmune thyroiditis. Travel Med Infect Dis. 2022;47:102314. https://doi.org/10.1016/j.tmaid.2022.102314.

16. Elhadd T, Gul W, Dabbous Z, Beer S, Bashir M. Bimodal distribution of thyroid dysfunction triggered by COVID-19 Infection: An experience from a single endocrine center-a case series and literature review. Qatar Med J. 2022;2022(3):39. https://doi.org/10.5339/qmj.2022.39.

17. Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411-417. (In Chinese.) https://doi.org/10.3760/cma.j.cn112151-20200312-00193.

18. Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M et al. Thyroid Function Before, During, and After COVID-19. J Clin Endocrinol Metab. 2021;106(2):e803-e811. https://doi.org/10.1210/clinem/dgaa830.

19. Geslot A, Chanson P, Caron P. Covid-19, the thyroid and the pituitary - The real state of play. Ann Endocrinol (Paris). 2022;83(2):103-108. https://doi.org/10.1016/j.ando.2021.12.004.

20. Daraei M, Hasibi M, Abdollahi H, Mirabdolhagh Hazaveh M, Zebaradst J, Hajinoori M, Asadollahi-Amin A. Possible role of hypothyroidism in the prognosis of COVID-19. Intern Med J. 2020;50(11):1410-1412. https://doi.org/10.1111/imj.15000.

21. Damara FA, Muchamad GR, Ikhsani R, Hendro, Syafiyah AH, Bashari MH. Thyroid disease and hypothyroidism are associated with poor COVID-19 outcomes: A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2021;15(6):102312. https://doi.org/10.1016/j.dsx.2021.102312.

22. Santare JA, Diaz TJ, Ahmed T, Durgham R, Liao W, Peacock E et al. Hypothyroidism May Be Associated with Post-COVID-19 Pulmonary Fibrosis. Thyroid. 2023;33(7):877-879. https://doi.org/10.1089/thy.2022.0724.

23. Qabuk SA, Cevher AZ, Kugukardali Y. Thyroid Function During and After COVID-19 Infection: A Review. Touch REV Endocrinol. 2022;18(1):58-62. https://doi.org/10.17925/EE.2022.18.1.58.

24. Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Pang P et al. Long COVID in Patients With Mild to Moderate Disease: Do Thyroid Function and Autoimmunity Play a Role? Endocr Pract. 2021;27(9):894-902. https://doi.org/10.1016/j.eprac.2021.06.016.

25. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2021;22(4):803-815. https//doi.org/10.1007/s11154-020-09615-z.

26. Burekovic A, Halilovic D, Sahbaz A. Hypothyroidism and Subclinical Hypothyroidism as a Consequence of COVID-19 Infection. Med Arch. 2022;76(1):12-16. https//doi.org/10.5455/medarh.2022.76.12-16.

27. Christensen J, O'Callaghan K, Sinclair H, Hawke K, Love A, Hajkowicz K, Stewart AG. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Intern Med J. 2022;52(4):522-529. https//doi.org/10.1111/imj.15432.

28. Whiting A, Reyes JVM, Ahmad S, Lieber J. Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism. Cureus. 2021;13(5):e14815. https://doi.org/10.7759/cureus.14815.

29. Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022;94(1):54-62. https//doi.org/10.1002/jmv.27292.

30. Świątkowska- Stodulska R, Berlińska A, Puchalska-Reglińska E. Thyroglobulin levels in COVID-19-positive patients: Correlations with thyroid function tests, inflammatory markers, and glucocorticoid use. Front Endocrinol (Lausanne). 2023;13:1031188. https://doi.org/10.3389/fendo.2022.1031188.

31. Vo HTM, Maestri A, Auerswald H, Sorn S, Lay S, Seng H et al. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort. Front Immunol. 2022;13:817905. https://doi.org/10.3389/fimmu.2022.817905.